| Cite this article: |
| QIU Kun,LIU Qi,WU Qiaona,LIU Jinglei,WANG Yujia,SU Yanlei,SUN Dianxing,ZHAO Jianyuan.Inhibitory activity of jaceosidin on the SARS-CoV-2 RNApolymerase[J].Journal Of Pharmaceutical Research,2026,45(2):130-133,149[Click to copy] |
|
| 摘要: |
| 目的 探索黄酮类小分子棕矢车菊素对新型冠状病毒RNA聚合酶的抑制活性。方法 运用分子对接技术研究棕矢车菊素在RNA聚合酶活性位点的结合模式,判断棕矢车菊素是否可以牢固地结合于RNA聚合酶的核苷酸底物(nucleoside triphosphates, NTPs)通道而阻碍原底物的进入;而后利用细胞水平的新型冠状病毒RNA聚合酶催化反应体系检测棕矢车菊素对RNA聚合酶的抑制性药理活性。结果 棕矢车菊素可结合于RNA聚合酶的活性位点处,占据NTPs通道而阻碍核苷酸底物的进入,从而实现抑制RNA聚合酶核酸复制的药理作用。细胞水平的药理实验结果发现,棕矢车菊素对新型冠状病毒RNA聚合酶具有一定程度的抑制活性,活性弱于瑞德西韦,但细胞毒性低于瑞德西韦。结论 本实验结果显示棕矢车菊素具有一定的RNA聚合酶抑制活性,本实验结果可为抗新型冠状病毒药物研发提供参考。 |
| 关键词: 新型冠状病毒 RNA聚合酶 活性位点 棕矢车菊素 分子对接 活性测试 |
| DOI:10.13506/j.cnki.jpr.2026.02.002 |
| 基金项目:河北省医学科研课题项目(No.20241370) |
|
Publication Date:February 25, 2026
|
|
| Inhibitory activity of jaceosidin on the SARS-CoV-2 RNApolymerase |
| QIU Kun1,LIU Qi2,WU Qiaona1,LIU Jinglei2,WANG Yujia3,SU Yanlei2,SUN Dianxing2,ZHAO Jianyuan3 |
| (1.The Third Hospital of Shijiazhuang,Shijiazhuang 050011,China;2.The 980th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army,Shijiazhuang 050082,China;3.Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China) |
| Abstract: |
| Objective To explore the inhibitory activity of the flavonoid jaceosidin against the RNA polymerase of the novel coronavirus.Methods Molecular docking was first employed to investigate the binding mode of jaceosidin at the active site of RNA polymerase, to determine whether jaceosidin could stably bind to the NTPs channel and obstruct the entry of substrates. Subsequently, the inhibitory pharmacological activity of jaceosidin against RNA polymerase was evaluated using a cell-based assay system for the catalytic reaction of the novel coronavirus RNA polymerase. Results Jaceosidin exhibited favorable binding to the active site of RNA polymerase, occupying the NTPs channel and hindering the entry of nucleotides, thereby achieving pharmacological action to inhibit RNA polymerase-mediated nucleic acid replication. The results of pharmacological experiments at the cellular level demonstrated that jaceosidin possesses inhibitory activity against RNA polymerase, albeit with weaker activity compared to remdesivir. However, jaceosidin exhibited lower cytotoxicity compared to remdesivir.Conclusion The findings of this study indicate that jaceosidin exhibits inhibitory activity against RNA polymerase, providing a potential reference for the development of anti-novel coronavirus drugs. |
| Key words: SARS-CoV-2 RNA polymerase Active site Jaceosidin Molecular dock Activity test |